Dr. David T. Ahn, MD
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
- Medicare participating
At a glance
- Medical school
- University of California, San Diego School of Medicine (2010)
- Years since graduation
- 16
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 527
Licensed in California since 2011, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Medical school: University of California, San Diego School of Medicine
- 2010Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
CA license A117662 (first issued 2011; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Hoag Memorial Hospital Presbyterian Newport Beach, CA
Medical groups
- David Ahn MD Inc (4 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 527
- Services billed
- 2,393
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 676 | 304 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 282 | 129 |
| New patient office or other outpatient visit, 45-59 minutes | 135 | 135 |
| New patient office or other outpatient visit, 60-74 minutes | 52 | 52 |
| Established patient office or other outpatient visit, 40-54 minutes | 28 | 24 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Ozempic (semaglutide) Other prescribers in Newport Beach, CA | 147 |
| Mounjaro (tirzepatide) Other prescribers in Newport Beach, CA | 90 |
| Metformin Hcl Er (metformin hcl) Other prescribers in Newport Beach, CA | 63 |
| Nano 2nd Gen Pen Needle (pen needle, diabetic) Other prescribers in Newport Beach, CA | 56 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Newport Beach, CA | 48 |
| Jardiance (empagliflozin) Other prescribers in Newport Beach, CA | 42 |
| Metformin Hcl Other prescribers in Newport Beach, CA | 41 |
| Levothyroxine Sodium Other prescribers in Newport Beach, CA | 39 |
| Testosterone Other prescribers in Newport Beach, CA | 32 |
| Rybelsus (semaglutide) Other prescribers in Newport Beach, CA | 32 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 14 companies reported 153 payments worth $119,242 in total to this clinician.
| Lilly USA, LLC | $23,219 |
|---|---|
| Novo Nordisk Inc | $22,342 |
| Ascensia Diabetes Care US Inc. | $17,994 |
| Abbott Laboratories | $10,863 |
| Eli Lilly and Company | $10,812 |
| Dexcom, Inc. | $10,426 |
| Insulet Corporation | $9,878 |
| Sequel Med Tech, LLC | $7,202 |
| Compensation for services other than consulting (speaking, faculty) | $66,556 |
|---|---|
| Speaking at a medical education program | $19,186 |
| Consulting Fee | $15,552 |
| Travel and Lodging | $11,203 |
| Honoraria | $3,620 |
| Food and Beverage | $3,126 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Ascensia Diabetes Care US Inc. Jul 10, 2025 | Compensation for services other than consulting (speaking, faculty) | $8,550 |
| Novo Nordisk Inc Mar 8, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $7,467 |
| Dexcom, Inc. Dec 5, 2025 | Speaking at a medical education program DEXCOM G7 GSS (161); DEXCOM STELO GLUCOSE BIOSENSOR · Endocrinology | $6,570 |
| Eli Lilly and Company Dec 12, 2025 | Consulting Fee | $5,500 |
| Lilly USA, LLC Feb 28, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $4,400 |
| Dexcom, Inc. Dec 15, 2025 | Speaking at a medical education program DEXCOM G7 GSS (161); DEXCOM STELO GLUCOSE BIOSENSOR · Endocrinology | $3,650 |
| Novo Nordisk Inc Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes Company’s descriptionThe reported payment reflects the amount provided to a third party employer or institution in connection with services provided by the covered recipient. Novo Nordisk Inc. does not know how much, if any, of this amount was actually received by the covered recipient. | $3,543 |
| Novo Nordisk Inc Jul 24, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes Company’s descriptionThe reported payment reflects the amount provided to a third party employer or institution in connection with services provided by the covered recipient. Novo Nordisk Inc. does not know how much, if any, of this amount was actually received by the covered recipient. | $3,543 |
| Novo Nordisk Inc May 28, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes Company’s descriptionThe reported payment reflects the amount provided to a third party employer or institution in connection with services provided by the covered recipient. Novo Nordisk Inc. does not know how much, if any, of this amount was actually received by the covered recipient. | $3,543 |
| Ascensia Diabetes Care US Inc. May 29, 2025 | Travel and Lodging travel to Amsterdam, Netherlands · in-kind | $3,197 |
All 85 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Insulet Corporation Dec 18, 2025 | Compensation for services other than consulting (speaking, faculty) OMNIPOD · Insulin Pump | $825 |
| Dexcom, Inc. Dec 15, 2025 | Speaking at a medical education program DEXCOM G7 GSS (161); DEXCOM STELO GLUCOSE BIOSENSOR · Endocrinology | $3,650 |
| Eli Lilly and Company Dec 12, 2025 | Consulting Fee | $5,500 |
| Eli Lilly and Company Dec 12, 2025 | Consulting Fee | $1,925 |
| Dexcom, Inc. Dec 5, 2025 | Speaking at a medical education program DEXCOM G7 GSS (161); DEXCOM STELO GLUCOSE BIOSENSOR · Endocrinology | $6,570 |
| Eli Lilly and Company Dec 3, 2025 | Travel and Lodging travel to INDIANAPOLIS, IN · in-kind | $783 |
| Abbott Laboratories Nov 26, 2025 | Speaking at a medical education program FREESTYLE LIBRE 3 · Diabetes Care | $2,553 |
| Abbott Laboratories Nov 26, 2025 | Speaking at a medical education program FREESTYLE LIBRE 3 · Diabetes Care | $1,188 |
| Abbott Laboratories Nov 26, 2025 | Speaking at a medical education program FREESTYLE LIBRE 3 · Diabetes Care | $950 |
| Abbott Laboratories Nov 26, 2025 | Travel and Lodging FREESTYLE LIBRE 3 · Diabetes Care · travel to Orlando, FL · in-kind | $372 |
| Abbott Laboratories Nov 26, 2025 | Travel and Lodging FREESTYLE LIBRE 3 · Diabetes Care · travel to Orlando, FL · in-kind | $156 |
| Insulet Corporation Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) OMNIPOD · Insulin Pump | $1,925 |
| Sequel Med Tech, LLC Oct 28, 2025 | Travel and Lodging TWIIST · AUTOMATED INSULIN DELIVERY DEVICE · travel to NEWPORT BEACH, CA | $1,861 |
| Sequel Med Tech, LLC Oct 28, 2025 | Consulting Fee TWIIST · AUTOMATED INSULIN DELIVERY DEVICE | $1,500 |
| Sequel Med Tech, LLC Oct 28, 2025 | Consulting Fee TWIIST · AUTOMATED INSULIN DELIVERY DEVICE | $750 |
| Lilly USA, LLC Oct 21, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,100 |
| Lilly USA, LLC Oct 14, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,100 |
| Novo Nordisk Inc Oct 7, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $579 |
| Senseonics, Incorporated Oct 2, 2025 | Compensation for services other than consulting (speaking, faculty) Eversense · Endocrinology | $400 |
| Insulet Corporation Sep 25, 2025 | Compensation for services other than consulting (speaking, faculty) OMNIPOD · Insulin Pump | $1,086 |
| Lilly USA, LLC Sep 15, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $2,200 |
| Lilly USA, LLC Sep 15, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,375 |
| Lilly USA, LLC Sep 10, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to PICO RIVERA, CA | $4.12 |
| Lilly USA, LLC Aug 28, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO; ZEPBOUND · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $550 |
| Novo Nordisk Inc Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes Company’s descriptionThe reported payment reflects the amount provided to a third party employer or institution in connection with services provided by the covered recipient. Novo Nordisk Inc. does not know how much, if any, of this amount was actually received by the covered recipient. | $3,543 |
| Sequel Med Tech, LLC Aug 19, 2025 | Consulting Fee TWIIST · AUTOMATED INSULIN DELIVERY DEVICE | $3,000 |
| Sequel Med Tech, LLC Aug 19, 2025 | Consulting Fee TWIIST · AUTOMATED INSULIN DELIVERY DEVICE | $26.60 |
| Sequel Med Tech, LLC Aug 19, 2025 | Travel and Lodging TWIIST · AUTOMATED INSULIN DELIVERY DEVICE · travel to NEWPORT BEACH, CA | $1.26 |
| Senseonics, Incorporated Aug 14, 2025 | Compensation for services other than consulting (speaking, faculty) Eversense · Endocrinology | $400 |
| Senseonics, Incorporated Aug 14, 2025 | Compensation for services other than consulting (speaking, faculty) Eversense · Endocrinology | $400 |
| Novo Nordisk Inc Aug 11, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes Company’s descriptionThe reported payment reflects the amount provided to a third party employer or institution in connection with services provided by the covered recipient. Novo Nordisk Inc. does not know how much, if any, of this amount was actually received by the covered recipient. | $1,363 |
| Novo Nordisk Inc Jul 24, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes Company’s descriptionThe reported payment reflects the amount provided to a third party employer or institution in connection with services provided by the covered recipient. Novo Nordisk Inc. does not know how much, if any, of this amount was actually received by the covered recipient. | $3,543 |
| Ascensia Diabetes Care US Inc. Jul 10, 2025 | Compensation for services other than consulting (speaking, faculty) | $8,550 |
| Abbott Laboratories Jun 27, 2025 | Speaking at a medical education program FREESTYLE LIBRE 3 · Diabetes Care | $2,138 |
| Abbott Laboratories Jun 27, 2025 | Speaking at a medical education program FREESTYLE LIBRE 3 · Diabetes Care | $1,188 |
| Abbott Laboratories Jun 27, 2025 | Speaking at a medical education program FREESTYLE LIBRE 3 · Diabetes Care | $950 |
| Lilly USA, LLC Jun 20, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,100 |
| Lilly USA, LLC Jun 17, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,100 |
| Ascensia Diabetes Care US Inc. Jun 3, 2025 | Consulting Fee | $2,850 |
| Lilly USA, LLC Jun 3, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,100 |
| Xeris Pharmaceuticals, Inc. Jun 2, 2025 | Honoraria GVOKE HYPOPEN · Diabetes | $2,070 |
| Xeris Pharmaceuticals, Inc. Jun 2, 2025 | Travel and Lodging GVOKE HYPOPEN · Diabetes · travel to Oklahoma City, OK | $16.80 |
| Lilly USA, LLC May 30, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,100 |
| Ascensia Diabetes Care US Inc. May 29, 2025 | Travel and Lodging travel to Amsterdam, Netherlands · in-kind | $3,197 |
| Novo Nordisk Inc May 28, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes Company’s descriptionThe reported payment reflects the amount provided to a third party employer or institution in connection with services provided by the covered recipient. Novo Nordisk Inc. does not know how much, if any, of this amount was actually received by the covered recipient. | $3,543 |
| Lilly USA, LLC May 16, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,100 |
| Abbott Laboratories May 16, 2025 | Travel and Lodging FREESTYLE LIBRE 3 · Diabetes Care · travel to Orlando, FL · in-kind | $438 |
| Abbott Laboratories May 16, 2025 | Travel and Lodging FREESTYLE LIBRE 3 · Diabetes Care · travel to Orlando, FL · in-kind | $335 |
| Abbott Laboratories May 16, 2025 | Travel and Lodging FREESTYLE LIBRE 3 · Diabetes Care · travel to Orlando, FL · in-kind | $45.00 |
| Abbott Laboratories May 16, 2025 | Travel and Lodging FREESTYLE LIBRE 3 · Diabetes Care · travel to Orlando, FL · in-kind | $45.00 |
| Abbott Laboratories May 16, 2025 | Travel and Lodging FREESTYLE LIBRE 3 · Diabetes Care · travel to Orlando, FL · in-kind | $9.02 |
| Lilly USA, LLC May 9, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO; ZEPBOUND · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,925 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $506 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $457 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $405 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $324 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $269 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $148 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $74.00 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $31.97 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $12.10 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $11.50 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $5.74 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $2.69 |
| Lilly USA, LLC May 1, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,100 |
| Lilly USA, LLC Apr 29, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,100 |
| Mannkind Corporation Apr 21, 2025 | Compensation for services other than consulting (speaking, faculty) AFREZZA · DIABETES MEDICINE | $1,275 |
| Lilly USA, LLC Apr 10, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,100 |
| Insulet Corporation Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) Omnipod · Insulin Pump | $1,650 |
| Insulet Corporation Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) Omnipod · Insulin Pump | $1,650 |
| Insulet Corporation Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) Omnipod · Insulin Pump | $1,086 |
| Ascensia Diabetes Care US Inc. Mar 27, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,088 |
| Lilly USA, LLC Mar 14, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to DENVER, CO | $60.00 |
| Lilly USA, LLC Mar 14, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to DENVER, CO | $18.20 |
| Novo Nordisk Inc Mar 8, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $7,467 |
| Novo Nordisk Inc Mar 8, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Orlando, FL · in-kind | $540 |
| Novo Nordisk Inc Mar 8, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Orlando, FL · in-kind | $399 |
| Novo Nordisk Inc Mar 8, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Orlando, FL · in-kind | $370 |
| Lilly USA, LLC Mar 7, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,100 |
| Xeris Pharmaceuticals, Inc. Mar 3, 2025 | Honoraria GVOKE HYPOPEN · Diabetes | $690 |
| Lilly USA, LLC Feb 28, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $4,400 |
| Insulet Corporation Feb 21, 2025 | Compensation for services other than consulting (speaking, faculty) Omnipod · Insulin Pump | $1,086 |
| Lilly USA, LLC Feb 21, 2025 | Travel and Lodging travel to DENVER, CO · in-kind | $303 |
| Insulet Corporation Jan 16, 2025 | Compensation for services other than consulting (speaking, faculty) Omnipod · Insulin Pump | $550 |
| Xeris Pharmaceuticals, Inc. Jan 14, 2025 | Honoraria GVOKE HYPOPEN · Diabetes | $860 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 7 industry-funded studies in 2025, from 4 companies. The companies reported $573,792 in research payments for these studies, mostly to the institutions running them.
- A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
Eli Lilly and Company · Active, not recruiting · NCT06662383 - A phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study evaluating the efficacy and long-term safety of tirzepatide once weekly compared to placebo in adults with type 1 diabetes and…
Eli Lilly and Company - Innovative Automated Insulin Delivery System for Type 2 Diabetes
Sequel Med Tech, LLC · Completed · NCT06853990 - M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
AbbVie Inc. - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
AbbVie Inc. · Active, not recruiting · NCT06345339 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
AbbVie Inc. - CIP341 IMPACT2
Medtronic, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.